UK Markets close in 3 hrs 20 mins
  • FTSE 100

    7,210.00
    -24.03 (-0.33%)
     
  • FTSE 250

    22,948.90
    -35.34 (-0.15%)
     
  • AIM

    1,235.51
    +6.41 (+0.52%)
     
  • GBP/EUR

    1.1842
    +0.0057 (+0.48%)
     
  • GBP/USD

    1.3739
    +0.0062 (+0.4548%)
     
  • BTC-GBP

    44,328.22
    -114.16 (-0.26%)
     
  • CMC Crypto 200

    1,424.84
    +18.10 (+1.29%)
     
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • DOW

    35,294.76
    +382.16 (+1.09%)
     
  • GOLD FUTURES

    1,762.70
    -5.60 (-0.32%)
     
  • NIKKEI 225

    29,025.46
    +474.56 (+1.66%)
     
  • HANG SENG

    25,409.75
    +447.15 (+1.79%)
     
  • DAX

    15,492.94
    -94.42 (-0.61%)
     
  • CAC 40

    6,672.43
    -55.09 (-0.82%)
     

Univar (UNVR) & Novozymes Tie-Up for Bio Solutions for Wastewater

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Univar Solutions Inc. UNVR recently announced an agreement with Novozymes, the leading player in biological solutions, which seeks to expand its footprint to include biological solutions for waste and wastewater treatment in the United States and Canada. The agreement follows previous announcements broadening the partnership to include a range of markets in the United States, Canada, and Latin America.

This agreement fortifies Univar’s services to municipal and industrial wastewater treatment plants, providing bio-augmentation, biogas, and sludge management enzymatic and microbial treatment solutions. Novozymes' advanced biotechnology provides biological solutions to traditional water and waste-treatment challenges such as sludge management, degradation of re-calcitration compounds, and biogas generation.

Univar is enthusiastic about the partnership. The addition of Novozymes' specialty biologic solutions to its portfolio strengthens its offerings to customers with complex water treatment requirements. The collaboration broadens Univar’s sustainable wastewater treatment capability that can be leveraged for gains.

Novozymes noted that the partnership will broaden its reach within the water industry through Univar’s panel of industry experts. With the advent of biology and biotechnology in industrial landscapes, which promise for the next industrial revolution, this partnership initiates a transition toward more sustainable, biological solutions in the water and waste industries.

Shares of Univar have appreciated 31% in a year compared with the industry’s rise of 20.7%. The estimated earnings growth rate for the company for the current year is 42.4%.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

The company expects adjusted EBITDA for third-quarter 2021 to be in the range of $175-$185 million and adjusted EBITDA in a band of $705-$725 million, implying an increase from $635.8 million reported in 2020. The forecast for net free cash flow for the year has been reiterated in the band of $280-$300 million.

Under the S22 Program, the company is focused on improving adjusted EBITDA margins to 9% by the end of 2022 and expects to reduce leverage to 2.7x or lower by the end of 2021. It also forecasts 2021 year-end liquidity to be more than $800 million, inclusive of $100 million of debt pay-down in the second half of the year. Univar expects more normalized margins and continued market share growth in the second half of 2021 as its aims for a more customer-centric approach.

Univar Solutions Inc. Price and Consensus

Univar Solutions Inc. Price and Consensus
Univar Solutions Inc. Price and Consensus

Univar Solutions Inc. price-consensus-chart | Univar Solutions Inc. Quote

Zacks Ranks & Stocks to Consider

Currently, Univar has a Zacks Rank #3 (Hold).

Better-ranked stocks in the basic materials space include Avient Corporation AVNT, Methanex Corporation MEOH, and Olin Corporation OLN, each flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Avient has a projected earnings growth rate of 75.1% for the current year. The company’s shares have surged 82.7% in a year.

Methanex has a projected earnings growth rate of 422.8% for the current year. The company’s shares have rallied 84.5% in a year.

Olin has a projected earnings growth rate of roughly 639.3% for the current year. The company’s shares have grown 259.9% in a year.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Methanex Corporation (MEOH) : Free Stock Analysis Report

Olin Corporation (OLN) : Free Stock Analysis Report

Univar Solutions Inc. (UNVR) : Free Stock Analysis Report

Avient Corporation (AVNT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting